MycoLogics, Inc. To Identify Novel Drug for Treatment of Leishmaniasis (Baghdad Boil)

MycoLogics, Inc., an innovative biotechnology company specializing in the development of novel drugs and vaccines for the prevention and treatment of infectious diseases, today announced the award of a Phase I SBIR grant by the National Institutes of Health to identify a lead drug compound for human clinical trials for the treatment of le...

Continue to MycoLogics, Inc. To Identify Novel Drug for Treatment of Leishmaniasis (Baghdad Boil) on PR Web (The Free Wire Service) Medical Infectious Diseases.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz